Archive

Tag: DETO2X

The DETO2X Trial: Do Patients with AMI Need Supplemental O2?

Background: Each year approximately 790,000 Americans suffer an acute myocardial infarction (AMI) (Benjamin 2017). Traditional treatment for an acute myocardial infarction has included morphine, oxygen, nitroglycerine and aspirin (MONA) with interventions such as percutaneous coronary intervention providing more definitive management. …

Read More
Cardiovascular

Sponsored